A STUDY WITH NORETHANDROLONE (NILEVAR) IN A MENTAL HOSPITAL ON PATIENTS WITH BOWEL AND BLADDER INCONTINENCE
Abstract
Norethandrolone was effective in controlling bowel and bladder incontinence in 10 of 13 patients who had been hospitalized for periods of from 6 months to 29 years. The most severely incontinent patients at the hospital were chosen for this study.
Upon conclusion of the study the improvement in 6 patients was excellent, in 1 good, in 3 fair improvement, in 2 it was unchanged, and one patient was dropped from the study because he refused to take the medication. A daily dose of 30 mg. by mouth was effective in most instances. No side effects were noted at any time during norethandrolone therapy. The mechanism by which norethandrolone exerts its anabolic action is not fully understood, and further studies in this area are planned. The results of this study are in agreement with those of Vaisberg and his co-workers and Vlavianos and his associates.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
